Clarius AI vs ElucidVivo A.3
AI Verdict
Choose Clarius AI if…
Choose Clarius AI if you require a highly portable, real-time ultrasound solution for point-of-care diagnostics, procedural guidance, or training in diverse clinical settings. Its integrated AI features excel at automating image optimization, providing anatomical overlays, and facilitating quick measurements, making it ideal for immediate visual feedback and enhanced workflow efficiency during live scans.
View Clarius AI →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if your primary need is advanced, quantitative analysis of arterial plaque composition and stability from CT angiography to stratify atherosclerosis patients and optimize treatment decisions. This tool is specifically designed for in-depth assessment of plaque characteristics, including lipid-rich necrotic core and calcifications, providing detailed 3D visualizations and FFRct derivation crucial for specialized cardiovascular care and research.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Clarius AI | ElucidVivo A.3 |
|---|---|---|
| Deployment | Cloud, Mobile App | Cloud and on-premise secure deployment. |
| FDA Status | Unknown | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Clarius AIClarius AI emphasizes ease of use with features like real-time guidance, voice controls, and mobile application integration, making advanced ultrasound more accessible at the point of care. ElucidVivo A.3, while powerful for specialized analysis, likely presents a steeper learning curve due to its advanced quantitative imaging features.
Clinical Value
ElucidVivo A.3ElucidVivo A.3 offers highly specialized and quantitative analysis of arterial plaque composition, validated against ground-truth histology, and derives fractional flow reserve (FFRct), providing deep, objective insights for atherosclerosis patient stratification and treatment optimization. While Clarius AI enhances point-of-care ultrasound, ElucidVivo A.3's specific, validated diagnostic capabilities for a critical cardiovascular condition offer a more profound clinical impact.
Pricing & Value
Clarius AIClarius AI provides transparent pricing with clear options for scanner purchase and an annual membership that unlocks advanced software, AI tools, and cloud storage, allowing for a predictable cost structure. ElucidVivo A.3 requires contacting the vendor for pricing, which lacks transparency and makes it difficult to assess its value proposition upfront.
Enterprise Readiness
Clarius AIClarius AI explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with FDA clearance and DICOM/PACS integration, offering clear assurances for enterprise adoption. While ElucidVivo A.3 is FDA-cleared and integrates with PACS/EMR, its HIPAA compliance and BAA availability are not explicitly stated in the provided information.
Innovation
ElucidVivo A.3ElucidVivo A.3 demonstrates significant innovation through its AI-powered quantitative analysis of arterial plaque composition and stability, validated on ground-truth histology, and its ability to derive FFRct, pushing the boundaries of non-invasive cardiovascular diagnostics. Clarius AI is innovative in making AI-powered handheld ultrasound accessible, but ElucidVivo A.3's specialized diagnostic depth is more groundbreaking.
Support & Docs
Clarius AIClarius AI explicitly mentions an 'Education Portal' as part of its membership, indicating structured support and educational resources for users. The provided information and web searches for ElucidVivo A.3 do not explicitly detail specific support channels or comprehensive documentation portals.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Clarius AI | ElucidVivo A.3 |
|---|---|---|
| Primary Function | Suite of artificial intelligence features integrated into handheld ultrasound scanners and app, designed to enhance image quality, automate measurements, and provide real-time guidance for clinicians across various specialties. | FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology. |
| Company | Clarius Mobile Health | Elucid Bioimaging |
| Core AI Application | Auto Preset AI for automatic image optimization and anatomy detection; Real-time AI labeling and anatomical overlays (T-Modeu2122) for training and guidance; Semi-automatic measurements for various structures (e.g., tendons, prostate, fetal biometrics); Voice controls for hands-free operation. | AI-powered quantitative analysis of arterial plaque, objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, visualizes lesion-level plaque composition, derives fractional flow reserve (FFRct). |
| Input Modality | Handheld ultrasound scanners | CT angiography images |
| Target Specialties | Emergency Medicine, Obstetrics & Gynecology, Radiology | Cardiology, Radiology, Vascular Surgery |
| Cloud Storage/Integration | Unlimited cloud storage and real-time telemedicine (with membership); DICOM/PACS integration (with membership); Integrated patient reports and CPT medical codes. | Integrates with PACS/EMR (not explicitly detailed regarding cloud storage). |
Videos
Demos, reviews, and walkthroughs featuring Clarius AI and ElucidVivo A.3.